Gastrointestinal Malignancies: Screening, Diagnosis, and Treatment

• Format: eBook
• Language: English
• Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
• Subjects: Medicine and Nursing; annexin A2; ascites; biliary tract cancer; c-Myc; calcium carbonate; cancer outcomes; cancer survivorship; CCL15; CCL2; CCL4; cigarette smoking; circulating tumor cell; colonoscopy screening; colorectal cancer; CRC; diagnosis; diagnostic utility; early gastric cancer; endoscopic submucosal dissection; endoscopy; esophageal cancer; gastrectomy; gastric cancer; gastric xanthelasma; gastrointestinal malignancies; genetic alteration; genetic linkage analysis; glycemic control; gynecologic cancer; HCV; hepatocellular carcinoma; hypercalcemia; insulin resistance; interferon; interval cancer; male; mortality; national cancer screening program; postoperative follow-up; predicting marker; prognosis; prognostic marker; retrospective cohort study; screening; survival; survival outcome; synchronous/metachronous gastric cancer; type 2 diabetes mellitus; vimentin
• Online Access: Open Access: DOAB: description of the publication; Open Access: DOAB, download the publication
• Physical Description: 1 online resource (154 p.)
• ISBN: 9783036593869; 9783036593876; books978-3-0365-9387-6
• Access: Open Access

Gastrointestinal (GI) malignancies represent a diverse spectrum of cancers with notable global incidence and prevalence. The comprehensive care of individuals affected by these malignancies is a multifaceted endeavor involving the collaboration of various medical disciplines. The nonspecific clinical manifestations of GI cancers often present a formidable diagnostic challenge to primary care providers, resulting in diagnostic delays. Subsequently, the treatment regimens, once initiated, are often demanding and prolonged, and profoundly impact the patients' overall quality of life. Given the intricate involvement of the digestive system, nutritional concerns are pervasive among these patients, influencing both their quality of life and survival. Despite these considerable challenges, the evolving landscape of treatment modalities has yielded improved outcomes, enabling a greater number of patients to achieve remission or extended survival. It is now imperative that we delve deeper into understanding the unique needs of this patient population and refine the care delivery pathways through enhanced diagnostic approaches, treatment strategies, and holistic support, and ultimately enhance the overall value of care provided to individuals afflicted by GI malignancies.